The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhruv Sureshkumar Jani
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.1 pts more than Nifty Microcap 250 and 4.9 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Promoter Dhruv Sureshkumar Jani sold 1,00,000 equity shares of Global Longlife Hospital and Research Ltd through the open market on December 10–11, 2025, under SEBI SAST Regulation 29(2). The sale represents 0.95% of the company's total equity share capital (Rs. 10.50 crore, 1.05 crore shares of Rs. 10 each). Post-sale, the promoter's holding stands at 37,48,990 shares, or 35.71% of the company, down from 36.66% held before the transaction.
This is a small (~1%) reduction in promoter stake via open market, which is routine but worth tracking since the promoter remains well below the 50% majority threshold at 35.71%, keeping the stock exposed to potential takeover or further stake changes.